SYNDAX PHARMACEUTICALS INC (SNDX) Stock Income Statement
USA - NASDAQ:SNDX - US87164F1057 - Common Stock
16.98 USD
-0.11 (-0.64%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 78.18M | 23.68M | 0 | 0 | 139.70M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | 830.00K | null | null | null | |||
| Gross Profit | null | 22.85M | null | null | null | |||
| Operating Expenses | 413.75M | 362.17M | 230.00M | 151.80M | 113.50M | |||
| Research and Development | 260.36M | 241.65M | 163.03M | 118.50M | 88.20M | |||
| Selling, General, and Administrative Expenses | 154.00M | 121.00M | 67.00M | 33.30M | 25.20M | |||
| Operating Income | -338.75M | -340.00M | -230.00M | -151.80M | 26.20M | |||
| Interest Income/Expense | 4.95M | 21.16M | 20.95M | 2.70M | -1.50M | |||
| Other Income/Expense | -890.00K | -250.00K | -360.00K | -300.00K | 200.00K | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -335.00M | -319.00M | -209.00M | -149.30M | 24.90M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -335.00M | -319.00M | -209.00M | -149.30M | 24.90M | |||
| EBITDA | null | -339.99M | -229.99M | -151.77M | 26.24M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.8800000000000003 | -3.72 | -2.98 | -2.46 | 0.46 | |||
| Non GAAP EPS | -3.89 | -3.73 | -2.96 | -2.4499999999999997 | 0.43000000000000016 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | 96.51% | N/A | N/A | N/A | |||
| Profit Margin | -428.50% | -1347.13% | N/A | N/A | 17.82% | |||
| Operating Profit Margin | -433.29% | -1435.81% | N/A | N/A | 18.75% | |||
All data in USD